|
ΒΙΒΛΙΟΓΡΑΦΙΚΕΣ ΑΝΑΦΟΡΕΣ:
1. Papatheodoridis G et al Liver Int. 2023 Sep;43(9):1879-1889 2. Miao Z, Zhang S, Ou X, et al. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis.2020;221(10):1677-1687. doi:10.1093/infdis/jiz633.2020;221(10):1677-1687. doi:10.1093/infdis/jiz633. 3. Stockdale AJ, Kreuels B, Henrion MYR, et al. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis.J Hepatol. 2020;73(3):523-532. doi:10.1016/j.jhep.2020.04.008 4. Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. J Hepatol 2021;74 (5):1200-1211.dol:10.1016/j.jhep:2021.01.014 5. Da BL, Heller T, Koh C. Hepatitis D Infection: from initial discovery to current investigational therapies. Gastroenterol Rep (Oxf) 2019;7 (4):231-245. dol: 10.1093/gastro/goz0235.
|
|
